The Shareholders Foundation, Inc. announces that a deadline is coming up on October 05, 2026, in the lawsuit that was filed for certain investors in ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) in the U.S. District Court for Southern District of California (No: 3:26-cv-04469).

Investors, who purchased shares in excess of $100,000 of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, have certain options and there are short and strict deadlines running. Deadline: October 5, 2026. Those NASDAQ: SPRY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 05, 2024, a NASDAQ: SPRY investor filed lawsuit against ARS Pharmaceuticals, Inc. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the defendants knew or recklessly disregarded potential timeline issues with CVS Caremark’s formulary addition and coverage decision related to neffy, that the guidance ARS Pharmaceuticals provided to investors related to the timeline for expansion of insurance coverage for neffy with CVS Caremark may be significantly shifted, impacting commercialization efforts; and that the expanded insurance coverage may not be available by the July 1 deadline, thus, ARS Pharmaceuticals would not have the expanded insurance coverage for neffy with CVS Caremark for the summer and back-to-school seasons.

Those who purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260915145339/en/

NASDAQ: SPRY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.